β-Blockers in dialysis patients: a nephrocardiology perspective

J Am Soc Nephrol. 2015 Apr;26(4):774-6. doi: 10.1681/ASN.2014080831. Epub 2014 Oct 30.

Authors

Gautam R Shroff¹, Charles A Herzog²

Affiliations

¹ Division of Cardiology, Department of Medicine, Hennepin County Medical Center and University of Minnesota, Minneapolis, Minnesota, and.
² Division of Cardiology, Department of Medicine, Hennepin County Medical Center and University of Minnesota, Minneapolis, Minnesota, and Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, Minnesota cherzog@cdrg.org.

No abstract available

Publication types

Editorial

MeSH terms

Adrenergic beta-Antagonists / therapeutic use*
Cardiovascular Diseases / prevention & control*
Humans
Kidney Failure, Chronic / complications*
Kidney Failure, Chronic / therapy
Renal Dialysis

Substances

Adrenergic beta-Antagonists